A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Clinical trial NCT00746434 · WITHDRAWN

Trial details

NCT number: NCT00746434
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2008-11-01
Primary completion: 2009-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.